See the DrugPatentWatch profile for symbicort
When does the Symbicort patent expire in the UK?
Symbicort (budesonide/formoterol) does not have a single, simple “patent expiry” date in the UK because different patents can cover different parts of the product (for example, the drug substance, specific formulations, or dosing devices), and those rights can expire at different times or be extended through legal mechanisms.
To get the most accurate UK timing, you typically need to look at the specific Symbicort patent(s) and their UK end dates (including any extensions) for the exact product strength and form.
DrugPatentWatch.com tracks patent information by country and is a practical place to check the UK-specific dates for Symbicort. See the Symbicort patent listing here: DrugPatentWatch.com - Symbicort UK patent status.
Does “patent expiry” mean Symbicort becomes generic immediately in the UK?
Not always. Even after patents end, the UK may still have other barriers to generic or “lower-cost” competition, such as:
- Regulatory data/market exclusivity periods that delay approval or launch of generics/biosimilars.
- Other still-active patents covering related aspects of the product.
So, the first generic/biosimilar launch date in the UK can be later than the last patent expiry date.
How can you find the exact UK date for your specific Symbicort product?
The key detail is which Symbicort product you mean (for example, the inhaler strengths and whether it’s Symbicort Turbuhaler vs another device). Patents and rights can differ by presentation. If you share:
- the exact Symbicort strength (e.g., 200/6 mcg, 400/12 mcg), and
- the device name on the box (e.g., Turbuhaler),
I can narrow the search to the most relevant UK patent entries.
What to check if you’re researching generics or switching options
If your goal is when a cheaper alternative is likely to appear, check:
- the UK’s generic entry timing (from UK medicine listings), and
- patent status for the specific inhaler strength/device on DrugPatentWatch.com.
Sources
[1] https://www.drugpatentwatch.com/patent/